Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lamivudine Tablets

Approval Number

国药准字H20223519

Company长春海悦药业股份有限公司

Registration Date

July 12, 2022

Drug Information

Generic Name

拉米夫定片

Dosage Form

片剂

Strength

0.1g

Drug Type

化学药品

Registration Date

July 12, 2022

Company Information

Applicant Company

Company Name长春海悦药业股份有限公司

Company Address

长春市双阳区长春双阳经济开发区双营大路5555号

Manufacturing Company

Company Name长春海悦药业股份有限公司

Company Address

长春市高新区创举街672号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy